About the Study

Help Future Generations, Today.

Respiratory syncytial virus, or RSV, is a common and very contagious virus that infects the respiratory tract of most children before their second birthday. Symptoms include congestion, cough and fever and very often are mild and short lived. However, in newborn children, the infection can be very serious and deadly. Newborns whose mothers have high levels of RSV antibodies have fewer infections with the virus.

This research study is to evaluate the safety and effectiveness of an investigational vaccine given to women between the ages of 18 – 45 to increase antibodies to RSV infection.

Qualifications

  • A female between the ages of 18-45
  • Not planning on conceiving a child for the next 10 months
  • BMI lower than 40 kg/m2
  • Generally Healthy
  • * Other conditions may apply